Retatrutide vs Tirzepatide Cost Per Mg: Comparing Listings
A breakdown of how retatrutide vs tirzepatide cost per mg is calculated from listing prices, why per-mg figures vary, and how to read them consistently.
Reviewed by Marcus Webb, PhD, research pharmacologist ·
Marcus Webb, PhD is a research pharmacologist with a doctorate from Johns Hopkins University and over 12 years of experience in receptor-selective peptide analogs, bioavailability science, and the pharmacoeconomics of emerging therapeutic compounds.
- retatrutide
- tirzepatide
- pricing
- comparison
Comparing retatrutide vs tirzepatide cost per mg means normalizing two listings that rarely quote prices the same way. One page might show a flat price per vial, another might show a price per milligram, and the vial sizes themselves are almost never identical between the two compounds. The only way to compare them fairly is to reduce both listings to the same unit: total listed price divided by total milligrams in the vial.
Why per-vial prices alone are misleading
A retatrutide listing priced at $250 for a 10 mg vial is not directly comparable to a tirzepatide listing priced at $180 for a 5 mg vial just by looking at the sticker price. The retatrutide vial costs more up front, but it also contains twice the peptide mass. Without dividing through, a reader could easily conclude the tirzepatide listing is cheaper when the reverse may be true once mass is accounted for.
This is the core reason per-mg normalization matters for any retatrutide vs tirzepatide cost per mg comparison: vial sizes across suppliers and even across a single supplier’s catalog are not standardized, so raw prices only tell part of the story.
Working out the per-mg figure
The calculation itself is simple arithmetic, not a formula specific to either compound:
price per mg = total listed price ÷ total mg in the vial
Using the example above:
- Retatrutide: $250 ÷ 10 mg = $25.00 per mg
- Tirzepatide: $180 ÷ 5 mg = $36.00 per mg
In this pairing, the retatrutide listing actually comes out lower on a per-mg basis, despite the higher vial price, because the vial holds more total peptide mass. Recomputing to check: $250 divided by 10 is 25, and $180 divided by 5 is 36. Both hold up.
This is why a retatrutide vs tirzepatide cost per mg comparison has to start with the vial size printed on the listing, not just the price tag next to it.
A quick reference table
| Listing | Vial size | Listed price | Price per mg |
|---|---|---|---|
| Retatrutide A | 10 mg | $250 | $25.00 |
| Retatrutide B | 5 mg | $140 | $28.00 |
| Tirzepatide A | 5 mg | $180 | $36.00 |
| Tirzepatide B | 10 mg | $310 | $31.00 |
Notice that price per mg varies within a single compound too. Retatrutide A and Retatrutide B are the same compound at different vial sizes, and they land at different per-mg figures. That spread is normal and reflects how suppliers price smaller and larger vials differently, not necessarily a difference in purity or sourcing.
Reconstitution changes concentration, not cost per mg
Once a vial is reconstituted with bacteriostatic water, the concentration in the syringe depends on how much diluent was added. Adding 2 mL of water to a 10 mg vial yields a concentration of 5 mg/mL, while adding 5 mL yields 2 mg/mL. On a U-100 insulin syringe, where 1 mL equals 100 units, that difference changes how many units correspond to a given mg amount, but it does not change what the vial cost to acquire. The per-mg price calculated from the listing stays fixed at the point of purchase; reconstitution only affects how that mass is measured out afterward. Readers working through this kind of math sometimes cross-check their arithmetic with a tool like peptcalc.com, which handles the mg-to-unit conversion once concentration is known.
Why listings differ in how they present price
Some sellers quote per-vial pricing because it mirrors how the product ships. Others quote per-mg pricing because it makes cross-vial-size comparison easier for the reader, and because it can make a smaller, cheaper-looking vial appear more or less competitive depending on the math. Neither format is inherently more honest, but a reader comparing retatrutide vs tirzepatide cost per mg across multiple sites needs to convert every listing to the same unit before drawing any conclusion. A page that only shows per-vial pricing is not hiding anything; it simply requires one extra division step.
Readers weighing this pairing often want the fuller compound picture rather than a single comparison, and a side-by-side reference like the one covering retatrutide alongside semaglutide and tirzepatide is useful context for spotting whether a per-mg price looks like an outlier or sits in line with the rest of the market.
Cross-checking across sources
Because vial sizes, diluent recommendations, and pricing structures vary by supplier, it helps to look at more than one listing before treating a per-mg figure as representative. Reference points from Retain Info and peer retatrutide listing catalogs can be useful for seeing how per-mg figures for retatrutide trend across different sellers, which gives more context than any single listing on its own.
Summary
Comparing retatrutide vs tirzepatide cost per mg requires dividing each listing’s total price by its total milligram content, since vial sizes for the two compounds are rarely matched. A higher vial price does not necessarily mean a higher per-mg cost, and per-mg figures can vary even within listings for the same compound. Reconstitution changes concentration and how a given mass is measured out on a syringe, but it does not change the per-mg price already fixed by the original listing.